Skip to content

Randomised trial, 2023

Does a one-week sleep and light intervention help PMDD mood symptoms?

A one-week intervention combining evening sleep restriction and morning bright light significantly improved mood more than the opposite pattern, and the benefit was linked to earlier timing of the body's melatonin rhythm. We can be fairly confident in this finding.

Moderate study design 44 women with premenstrual dysphoric disorder confirmed by DSM-5 criteria at a university research clinic

What they did

44 women with confirmed PMDD were randomized to one of two interventions: one night of restricted sleep (9pm-1am) plus 7 days of morning bright light, or one night of sleep (3am-7am) plus 7 days of evening bright light. After one month rest, they received the alternate intervention. Researchers measured mood, melatonin, and sleep activity.

What they found

The morning light plus evening sleep restriction intervention advanced melatonin timing more than the evening light intervention (p<.05) and improved mood scores more (p<.05). Mood improvement significantly correlated with earlier timing of melatonin (p<.001). At baseline, atypical depression correlated with delayed melatonin timing (r=.456, p=.038).

What it means for you

A simple non-drug intervention combining evening sleep restriction with morning light may help PMDD mood by shifting the body's clock earlier. It's quick (one week), safe, and home-based with no side effects. However, the study focused on depression-related mood, not all PMDD symptoms. The specific sleep timing may not suit everyone.

44

women with PMDD

1 week

duration of intervention

p<.001

mood improvement correlation

About the study

Original title
A 1-week sleep and light intervention improves mood in premenstrual dysphoric disorder in association with shifting melatonin offset time earlier
Authors
Parry BL, Meliska CJ, Martinez LF et al.
Journal
Archives of women's mental health
Year
2023
Study design
Randomised trial
Participants
44
What was tested
Phase-advance sleep and light intervention versus phase-delay sleep and light intervention
Open access
Yes
Original abstract

To test the hypothesis that 1 week of combined sleep and light interventions (SALI), which phase-advance (shift earlier) melatonin circadian rhythms, improves mood significantly more than phase-delay (shift later) SALI. After a 2-month diagnostic evaluation for premenstrual dysphoric disorder (PMDD per DSM-5 criteria) in a university clinical research setting, 44 participants enrolled in baseline studies were randomized in the luteal phase at home to (A) a phase-advance intervention (PAI): 1 night of late-night wake therapy (LWT: sleep 9 pm-1 am) followed by 7 days of the morning (AM) bright white light (BWL), or (B) a phase-delay intervention (PDI): 1 night of early-night wake therapy (EWT: sleep 3-7 am) plus 7 days of the evening (PM) BWL. After a month of no intervention, participants underwent the alternate intervention. Outcome measures were mood, the melatonin metabolite, 6-sulfatoxymelatonin (6-SMT), and actigraphy (to assess protocol compliance). At baseline, atypical depression correlated positively with phase delay in 6-SMT offset time (r = .456, p = .038). PAI advanced 6-SMT offset from baseline more than PDI (p < .05), and improved raw mood scores more than PDI (p < .05). As hypothesized, percent improvement in mood correlated positively with a phase advance from baseline in 6-SMT offset time (p < .001). Treatment with 1 night of advanced/restricted sleep followed by 7 days of AM BWL (PAI) was more efficacious in reducing PMDD depression symptoms than a PDI; mood improvement occurred in association with phase advance in 6-SMT offset time. Combined SALIs offer safe, efficacious, rapid-acting, well-tolerated, non-pharmacological, non-hormonal, affordable, repeatable home interventions for PMDD. Clinical Trials.gov NCT # NCT01799733.

Reproduced under CC-BY.

Topics